WVE

Wave Life Sciences Stock Analysis

AI Rating

Low
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 0/10
Wave Life Sciences sales and earnings growth
WVE Growth
Fair
  • Revenue Y/Y↓ -60.55%
  • EPS Y/Y↓ -72.86%
  • FCF Y/Y↓ -23.85%
Wave Life Sciences gross and profit margin trends
WVE Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -478.30%
  • ROIC 5Y↑ 3253.88%
Wave Life Sciences net debt vs free cash flow
WVE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Wave Life Sciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗